The Company possesses a growing portfolio of specialty enzyme products and unique technical and operational capabilities designed to enable the production of low-cost, biomass-derived sugars.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
It is hard to rate bio-tech companies. It is harder still to rate bio-tech start-ups with nothing but losses in their history. But BP's $90 million investment is a re-assuring vote of confidence. Their ethanol technology is based on non-food crops (energy cane, etc.) so, unlike corn, should not precipitate a backlash crisis in rising food prices.